KYOWA KIRIN CO., LTD.
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
A Phase 3 Clinical Study of KHK4827
- First Posted Date
- 2013-02-04
- Last Posted Date
- 2015-02-16
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 145
- Registration Number
- NCT01782924
- Locations
- 🇯🇵
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin, Chiyoda-ku, Tokyo, Japan
An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis
- First Posted Date
- 2013-02-04
- Last Posted Date
- 2015-02-16
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT01782937
- Locations
- 🇯🇵
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin, Chiyoda-ku, Tokyo, Japan
A Phase 2 Clinical Study of KHK4827
- Conditions
- Moderate to Severe Plaque Psoriasis
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-12-12
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 140
- Registration Number
- NCT01748539
- Locations
- 🇯🇵
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin, Chiyoda-ku, Tokyo, Japan
Study of ARQ 197 in Hepatocellular Carcinoma (HCC)
- First Posted Date
- 2012-08-02
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT01656265
Along-term Study of OPC-262 in Patients With Type 2 Diabetes
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 222
- Registration Number
- NCT01634282
Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)
- Conditions
- Peripheral T-Cell Lymphoma
- Interventions
- Biological: KW-0761 (mogamulizumab)
- First Posted Date
- 2012-06-04
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT01611142
- Locations
- 🇪🇸
Institut Catalá D'Oncologia, Hospital Duran y Reynals, Barcelona, Spain
🇪🇸Hospital Univesitario 12 de Octubre, Madrid, Spain
🇬🇧Christie Hospital, Manchester, United Kingdom
ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer
- First Posted Date
- 2012-04-19
- Last Posted Date
- 2015-08-18
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT01580735
A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
- First Posted Date
- 2012-04-10
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 53
- Registration Number
- NCT01574365
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
- First Posted Date
- 2012-04-06
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 11
- Registration Number
- NCT01572610
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
- First Posted Date
- 2012-04-05
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 23
- Registration Number
- NCT01571596
- Locations
- 🇺🇸
University of Texas Health Science Center at Houston, Houston, Texas, United States
🇺🇸Duke Clinical Research Unit, Durham, North Carolina, United States
🇺🇸University of California San Francisco, San Francisco, California, United States